Progyny, Inc. (PGNY) Insider Trading Activity

NASDAQ$26.01
Market Cap
$2.24B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
57 of 823
Rank in Industry
3 of 35

PGNY Insider Trading Activity

PGNY Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$7,167,310
3
25
Sells
$821,107
9
75

Related Transactions

Anevski PeterCHIEF EXECUTIVE OFFICER
2
$4.96M
0
$0
$4.96M
Schlanger David JExecutive Chairman
1
$2.2M
0
$0
$2.2M
GORDON KEVIN Kdirector
0
$0
1
$55,088
$-55,088
Scott Cheryldirector
0
$0
1
$59,037
$-59,037
Swartz AllisonEVP, GC
0
$0
4
$146,620
$-146,620
Livingston Mark S.CHIEF FINANCIAL OFFICER
0
$0
3
$560,363
$-560,363

About Progyny, Inc.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Insider Activity of Progyny, Inc.

Over the last 12 months, insiders at Progyny, Inc. have bought $7.17M and sold $821,107 worth of Progyny, Inc. stock.

On average, over the past 5 years, insiders at Progyny, Inc. have bought $7.17M and sold $159.12M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Anevski Peter (CHIEF EXECUTIVE OFFICER) — $4.96M. Schlanger David J (Executive Chairman) — $2.2M.

The last purchase of 79,500 shares for transaction amount of $1.93M was made by Anevski Peter (CHIEF EXECUTIVE OFFICER) on 2025‑11‑13.

List of Insider Buy and Sell Transactions, Progyny, Inc.

2025-12-11SaleLivingston Mark S.CHIEF FINANCIAL OFFICER
459
0.0005%
$25.50
$11,705
+5.43%
2025-12-04SaleSwartz AllisonEVP, GC
530
0.0006%
$24.59
$13,033
+4.33%
2025-12-02SaleLivingston Mark S.CHIEF FINANCIAL OFFICER
213
0.0003%
$25.50
$5,432
-0.71%
2025-11-28SaleSwartz AllisonEVP, GC
2,398
0.0028%
$26.87
$64,434
-5.61%
2025-11-17SaleLivingston Mark S.CHIEF FINANCIAL OFFICER
21,303
0.0235%
$25.50
$543,227
-4.52%
2025-11-13PurchaseAnevski PeterCHIEF EXECUTIVE OFFICER
79,500
0.0917%
$24.29
$1.93M
+4.86%
2025-09-04SaleSwartz AllisonEVP, GC
599
0.0007%
$23.53
$14,094
-6.83%
2025-08-28SaleSwartz AllisonEVP, GC
2,398
0.0028%
$22.96
$55,058
-4.30%
2025-08-11SaleGORDON KEVIN Kdirector
2,500
0.003%
$22.04
$55,088
+3.72%
2025-06-11SaleScott Cheryldirector
2,675
0.0032%
$22.07
$59,037
+4.36%
2024-12-26PurchaseSchlanger David JExecutive Chairman
150,000
0.1758%
$14.68
$2.2M
+49.90%
2024-12-23PurchaseAnevski PeterCHIEF EXECUTIVE OFFICER
209,500
0.2451%
$14.48
$3.03M
+51.97%
2024-11-23SalePayson Normandirector
200
0.0003%
$56.29
$11,258
-72.57%
2024-07-16SaleSturmer Michael EPRESIDENT
9,030
0.0103%
$30.00
$270,900
-28.43%
2024-06-28SaleScott Cheryldirector
1,462
0.0016%
$28.39
$41,506
-24.85%
2024-05-01SaleSturmer Michael EPRESIDENT
4,515
0.0046%
$31.95
$144,254
-32.22%
2024-04-01SaleSturmer Michael EPRESIDENT
6,395
0.0068%
$37.60
$240,452
-39.50%
2024-04-01SaleSchlanger David JExecutive Chairman
1,000
0.0011%
$37.52
$37,523
-39.50%
2024-04-01SaleLivingston Mark S.CHIEF FINANCIAL OFFICER
11,165
0.0119%
$37.62
$419,979
-39.50%
2024-03-27SaleSchlanger David JExecutive Chairman
71,272
0.0735%
$37.80
$2.69M
-41.77%
Total: 623
*Gray background shows transactions not older than one year

Insider Historical Profitability

60.32%
Anevski PeterCHIEF EXECUTIVE OFFICER
680251
0.789%
$17.69M2112
Schlanger David JExecutive Chairman
228269
0.2648%
$5.94M1135
Swartz AllisonEVP, GC
72719
0.0843%
$1.89M04
Livingston Mark S.CHIEF FINANCIAL OFFICER
46983
0.0545%
$1.22M013
Scott Cheryldirector
14112
0.0164%
$367,053.1205
GORDON KEVIN Kdirector
12501
0.0145%
$325,151.0103
TPG Group Holdings (SBS) Advisors, Inc.10 percent owner
10000000
11.5994%
$260.1M095
SEIDENBERG BETH Cdirector
8805015
10.2133%
$229.02M14
+60.32%
KLEINER PERKINS CAUFIELD & BYERS XIII, LLC10 percent owner
8805015
10.2133%
$229.02M01
TPG GP A, LLC
6350000
7.3656%
$165.16M02
GLAXOSMITHKLINE PLC10 percent owner
6238244
7.236%
$162.26M01
Ajmani KarinEVP, Chief of Strategic Dev.
638043
0.7401%
$16.6M01
Payson Normandirector
580656
0.6735%
$15.1M0201
Sturmer Michael EPRESIDENT
362583
0.4206%
$9.43M08
Bealer JenniferEVP, General Counsel
69416
0.0805%
$1.81M021
Greenbaum LisaEVP, Chief Client Officer
11746
0.0136%
$305,513.46013
*Gray background shows insiders who have made transactions during last year

PGNY Institutional Investors: Active Positions

Increased Positions183+63.99%9M+11.23%
Decreased Positions123-43.01%8M-10.26%
New Positions44New1MNew
Sold Out Positions35Sold Out1MSold Out
Total Postitions346+20.98%83M+0.97%

PGNY Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$395,757.0017.23%14.82M+235,302+1.61%2025-09-30
Vanguard Group Inc$269,935.0011.75%10.11M+235,513+2.39%2025-09-30
Fmr Llc$175,461.007.64%6.57M+2M+39.39%2025-09-30
State Street Corp$77,687.003.38%2.91M+41,045+1.43%2025-09-30
Thrivent Financial For Lutherans$57,648.002.51%2.16M-3M-55.85%2025-09-30
Geode Capital Management, Llc$52,130.002.27%1.95M+207,578+11.9%2025-09-30
Arrowmark Colorado Holdings Llc$51,584.002.25%1.93M+39,666+2.1%2025-09-30
Ameriprise Financial Inc$50,477.002.2%1.89M-107,132-5.37%2025-09-30
Fred Alger Management, Llc$45,585.001.98%1.71M-49,410-2.81%2025-09-30
Fort Washington Investment Advisors Inc /Oh/$44,247.001.93%1.66M+412,395+33.15%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.